Learn more about Evernorth Therapy Link, a new solution designed to identify and support patients who can benefit most from gene or cell therapies.

Breaking down the challenges, therapies and costs associated with hemophilia.

At Accredo by Evernorth, we’re witnessing a transformation in neurological care as innovative treatments move from research to reality.

As treatment for hemophilia evolves, data proves a good specialty pharmacy partner can help minimize waste and drive efficient practices.

Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...

An integrated approach to managing medically billed specialty drugs is key to optimizing cost savings and clinical outcomes.

The ever-evolving complexity of medications billed through the medical benefit requires continuous investment in processes to manage their increasingly high price tag.